Join
Live feed
·
INSIDERFilingvia Quantisnow
bioAffinity Technologies Inc. logo

President & CEO Zannes Maria was granted 37,037 shares, increasing direct ownership by 15% to 280,359 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
BIAF· bioAffinity Technologies Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track BIAF (bioAffinity Technologies Inc.) and more on Quantisnow.